| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |